GYY 4137 attenuated renal ischemia-reperfusion injury by protecting against oxidative stress , apoptosis and inflammation

Hongchao Zhao,Yang Du,Xiuheng Liu,Hengcheng Zhu

2017-01-01

Abstract:Hydrogen sulfide (H2S) has been known as a gasotransmitter in renal ischemia-reperfusion injury (RIRI) for years. GYY4137 as a novel, water-soluble, slow-releasing H2S donor has attracted more and more concern recently. The aim of this study is to investigate the efficacy of GYY4137 in protecting against renal IRI. Male Sprague-Dawley rats were treated with GYY4137 10 ml at different concentration intraperitoneally (100, 200, 400 μmol/L). Then, rats were subjected to 45 min of left renal pedicle occlusion followed by reperfusion of 24 hours. We found that GYY4137 decreased Scr and BUN, alleviated histological injury and cellular apoptosis after renal I/R. GYY4137 also decreased MDA and increased SOD levels in serum, attenuated oxidative stress after renal I/R. Meanwhile, GYY4137 increased the expression of Bcl-2 and decreased the expression of Bax, NF-κB and caspase-3 activity to inhibit apoptosis. GYY4137 decreased the inflammatory factors significantly, included TNF-A, ICAM-1, IL-2 and IL-6. In conclusion, the results demonstrated that GYY4137 protects against renal ischemia-reperfusion injury by attenuating oxidative stress, apoptosis and inflammation. This might be a much promising therapy in ameliorating renal IRI in clinic.